Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Int J Biol Macromol. 2024 Oct;277(Pt 4):134537. doi: 10.1016/j.ijbiomac.2024.134537. Epub 2024 Aug 5.
As one of rare high-value ocotillol (OCT)-type ginsenosides, pseudoginsenoside Rt5 has been identified with significant pharmacological activities. UDP-glycosyltransferases (UGTs) play pivotal roles in catalyzing the transfer of a glycosyl moiety from a donor to an acceptor. In this study, the novel UGT, PjUGT10, was screened from the transcriptome database of Panax japonicus and identified with the enzymatic activity of transferring a glucosyl group on OCT to produce Rt5. The catalytic efficiency of PjUGT10 was further enhanced by employing site-directed mutation. Notably, the variant M7 exhibited a remarkable 6.16 × 10-fold increase in k/K towards 20S,24R-ocotillol and a significant 2.02 × 10-fold increase to UDP-glucose, respectively. Moreover, molecular dynamics simulations illustrated a reduced distance between 20S,24R-ocotillol and the catalytic residue His15 or UDP-glucose, favoring conformation interactions between the enzyme and substrates. Subsequently, Rt5 was synthesized in an engineered Escherichia coli strain M7 coupled with a UDP-glucose synthetic system. This study not only shed light on the protein engineering that can enhance the catalytic activity of PjUGT10, but also established a whole-cell approach for the production of Rt5.
作为一种罕见的高价值奥克梯隆(OCT)型人参皂苷,假人参皂苷 Rt5 已被确定具有显著的药理活性。尿苷二磷酸-糖基转移酶(UGTs)在催化糖基部分从供体转移到受体方面发挥着关键作用。在这项研究中,从人参转录组数据库中筛选出新型 UGT,PjUGT10,并鉴定其具有将 OCT 上的葡萄糖基转移到产生 Rt5 的酶活性。通过定点突变进一步提高了 PjUGT10 的催化效率。值得注意的是,变体 M7 对 20S,24R-奥克梯隆的 k/K 值分别显著提高了 6.16×10 倍和对 UDP-葡萄糖的提高了 2.02×10 倍。此外,分子动力学模拟表明 20S,24R-奥克梯隆与催化残基 His15 或 UDP-葡萄糖之间的距离减小,有利于酶与底物之间的构象相互作用。随后,在与 UDP-葡萄糖合成系统偶联的工程大肠杆菌菌株 M7 中合成了 Rt5。本研究不仅阐明了可以提高 PjUGT10 催化活性的蛋白质工程,而且还建立了一种用于生产 Rt5 的全细胞方法。